Evidence map›Paper›PMID 36869605›Full record

ArticleThe Journal of physiology2023

Antagonism of TRPV4 channels partially reduces mechanotransduction in rat skeletal muscle afferents.

Ayumi Fukazawa, Amane Hori, Norio Hotta, Kimiaki Katanosaka, Juan A Estrada, Rie Ishizawa, Han-Kyul Kim, Gary A Iwamoto, Scott A Smith, Wanpen Vongpatanasin and 1 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of physiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Ayumi FukazawaDepartments of, Applied Clinical Research, Internal Medicine, and Surgery, School of Health Professions, University of Texas Southwestern Medical Center, Dallas, TX, USA.ORCID 0000-0002-7322-043X
Amane HoriGraduate School of Life and Health Sciences, Chubu University, Kasugai, Japan.
Norio HottaGraduate School of Life and Health Sciences, Chubu University, Kasugai, Japan.
Kimiaki KatanosakaGraduate School of Life and Health Sciences, Chubu University, Kasugai, Japan.ORCID 0000-0002-4866-6536
Juan A EstradaDepartments of, Applied Clinical Research, Internal Medicine, and Surgery, School of Health Professions, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Rie IshizawaDepartments of, Applied Clinical Research, Internal Medicine, and Surgery, School of Health Professions, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Han-Kyul KimDepartments of, Applied Clinical Research, Internal Medicine, and Surgery, School of Health Professions, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Gary A IwamotoDepartments of, Applied Clinical Research, Internal Medicine, and Surgery, School of Health Professions, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Scott A SmithDepartments of, Applied Clinical Research, Internal Medicine, and Surgery, School of Health Professions, University of Texas Southwestern Medical Center, Dallas, TX, USA.ORCID 0000-0002-2143-2342
Wanpen VongpatanasinDepartments of, Applied Clinical Research, Internal Medicine, and Surgery, School of Health Professions, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Masaki MizunoDepartments of, Applied Clinical Research, Internal Medicine, and Surgery, School of Health Professions, University of Texas Southwestern Medical Center, Dallas, TX, USA.ORCID 0000-0003-4455-8084
The University of Texas Southwestern Medical Center · USChubu University · JP

Funding

TARGETING INSULIN RESISTANCE TO IMPROVE ABNORMAL CARDIOVASCULAR CONTROL IN DIABETESR01HL151632 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI MIZUNO, MASAKI · 2020 to 2023
$1.8M
NHLBI NIH HHS R01 HL151632
6 · The paper itself

Abstract

Mechanical distortion of working skeletal muscle induces sympathoexcitation via thin fibre afferents, a reflex response known as the skeletal muscle mechanoreflex. However, to date, the receptor ion channels responsible for mechanotransduction in skeletal muscle remain largely undetermined. Transient receptor potential vanilloid 4 (TRPV4) is known to sense mechanical stimuli such as shear stress or osmotic pressure in various organs. It is hypothesized that TRPV4 in thin-fibre primary afferents innervating skeletal muscle is involved in mechanotransduction. Fluorescence immunostaining revealed that 20.1 ± 10.1% of TRPV4 positive neurons were small dorsal root ganglion (DRG) neurons that were DiI-labelled, and among them 9.5 ± 6.1% of TRPV4 co-localized with the C-fibre marker peripherin. In vitro whole-cell patch clamp recordings from cultured rat DRG neurons demonstrated that mechanically activated current amplitude was significantly attenuated after the application of the TRPV4 antagonist HC067047 compared to control (P = 0.004). Such reductions were also observed in single-fibre recordings from a muscle-nerve ex vivo preparation where HC067047 significantly decreased afferent discharge to mechanical stimulation (P = 0.007). Likewise, in an in vivo decerebrate rat preparation, the renal sympathetic nerve activity (RSNA) and mean arterial pressure (MAP) responses to passive stretch of hindlimb muscle were significantly reduced by intra-arterial injection of HC067047 (ΔRSNA: P = 0.019, ΔMAP: P = 0.002). The findings suggest that TRPV4 plays an important role in mechanotransduction contributing to the cardiovascular responses evoked by the skeletal muscle mechanoreflex during exercise. KEY POINTS: Although a mechanical stimulus to skeletal muscle reflexively activates the sympathetic nervous system, the receptors responsible for mechanotransduction in skeletal muscle thin fibre afferents have not been fully identified. Evidence suggests that TRPV4 is a mechanosensitive channel that plays an important role in mechanotransduction within various organs. Immunocytochemical staining demonstrates that TRPV4 is expressed in group IV skeletal muscle afferents. In addition, we show that the TRPV4 antagonist HC067047 decreases the responsiveness of thin fibre afferents to mechanical stimulation at the muscle tissue level as well as at the level of dorsal root ganglion neurons. Moreover, we demonstrate that intra-arterial HC067047 injection attenuates the sympathetic and pressor responses to passive muscle stretch in decerebrate rats. These data suggest that antagonism of TRPV4 attenuates mechanotransduction in skeletal muscle afferents. The present study demonstrates a probable physiological role for TRPV4 in the regulation of mechanical sensation in somatosensory thin fibre muscle afferents.

Indexed as

Transient Receptor Potential ChannelsTRPV Cation ChannelsAnimalsBlood PressureMechanotransduction, CellularMorpholinesMuscle ContractionMuscle, SkeletalPyrrolesRatsRats, Sprague-DawleyReflexHC-067047MorpholinesPyrrolesTransient Receptor Potential ChannelsTrpv4 protein, ratTRPV Cation Channelsgroup IV muscle afferentsmechanotransductionmuscle mechanoreflexprimary sensory neurontransient receptor potential vanilloid 4

Identifiers

PMID36869605
PMCPMC10106437
OpenAlexW4323067135

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.